Cargando…
Origin of myofibroblasts in liver fibrosis
Most chronic liver diseases of all etiologies result in progressive liver fibrosis. Myofibroblasts produce the extracellular matrix, including type I collagen, which constitutes the fibrous scar in liver fibrosis. Normal liver has little type I collagen and no detectable myofibroblasts, but myofibro...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3368775/ https://www.ncbi.nlm.nih.gov/pubmed/23259769 http://dx.doi.org/10.1186/1755-1536-5-S1-S17 |
_version_ | 1782234988044877824 |
---|---|
author | Brenner, David A Kisseleva, Tatiana Scholten, David Paik, Yong Han Iwaisako, Keiko Inokuchi, Sayaka Schnabl, Bernd Seki, Ekihiro De Minicis, Samuele Oesterreicher, Christoph Taura, Kojiro |
author_facet | Brenner, David A Kisseleva, Tatiana Scholten, David Paik, Yong Han Iwaisako, Keiko Inokuchi, Sayaka Schnabl, Bernd Seki, Ekihiro De Minicis, Samuele Oesterreicher, Christoph Taura, Kojiro |
author_sort | Brenner, David A |
collection | PubMed |
description | Most chronic liver diseases of all etiologies result in progressive liver fibrosis. Myofibroblasts produce the extracellular matrix, including type I collagen, which constitutes the fibrous scar in liver fibrosis. Normal liver has little type I collagen and no detectable myofibroblasts, but myofibroblasts appear early in experimental and clinical liver injury. The origin of the myofibroblast in liver fibrosis is still unresolved. The possibilities include activation of endogenous mesenchymal cells including fibroblasts and hepatic stellate cells, recruitment from the bone marrow, and transformation of epithelial or endothelial cells to myofibroblasts. In fact, the origin of myofibroblasts may be different for different types of chronic liver diseases, such as cholestatic liver disease or hepatotoxic liver disease. This review will examine our current understanding of the liver myofibroblast. |
format | Online Article Text |
id | pubmed-3368775 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-33687752012-06-07 Origin of myofibroblasts in liver fibrosis Brenner, David A Kisseleva, Tatiana Scholten, David Paik, Yong Han Iwaisako, Keiko Inokuchi, Sayaka Schnabl, Bernd Seki, Ekihiro De Minicis, Samuele Oesterreicher, Christoph Taura, Kojiro Fibrogenesis Tissue Repair Proceedings Most chronic liver diseases of all etiologies result in progressive liver fibrosis. Myofibroblasts produce the extracellular matrix, including type I collagen, which constitutes the fibrous scar in liver fibrosis. Normal liver has little type I collagen and no detectable myofibroblasts, but myofibroblasts appear early in experimental and clinical liver injury. The origin of the myofibroblast in liver fibrosis is still unresolved. The possibilities include activation of endogenous mesenchymal cells including fibroblasts and hepatic stellate cells, recruitment from the bone marrow, and transformation of epithelial or endothelial cells to myofibroblasts. In fact, the origin of myofibroblasts may be different for different types of chronic liver diseases, such as cholestatic liver disease or hepatotoxic liver disease. This review will examine our current understanding of the liver myofibroblast. BioMed Central 2012-06-06 /pmc/articles/PMC3368775/ /pubmed/23259769 http://dx.doi.org/10.1186/1755-1536-5-S1-S17 Text en Copyright ©2012 Brenner et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Proceedings Brenner, David A Kisseleva, Tatiana Scholten, David Paik, Yong Han Iwaisako, Keiko Inokuchi, Sayaka Schnabl, Bernd Seki, Ekihiro De Minicis, Samuele Oesterreicher, Christoph Taura, Kojiro Origin of myofibroblasts in liver fibrosis |
title | Origin of myofibroblasts in liver fibrosis |
title_full | Origin of myofibroblasts in liver fibrosis |
title_fullStr | Origin of myofibroblasts in liver fibrosis |
title_full_unstemmed | Origin of myofibroblasts in liver fibrosis |
title_short | Origin of myofibroblasts in liver fibrosis |
title_sort | origin of myofibroblasts in liver fibrosis |
topic | Proceedings |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3368775/ https://www.ncbi.nlm.nih.gov/pubmed/23259769 http://dx.doi.org/10.1186/1755-1536-5-S1-S17 |
work_keys_str_mv | AT brennerdavida originofmyofibroblastsinliverfibrosis AT kisselevatatiana originofmyofibroblastsinliverfibrosis AT scholtendavid originofmyofibroblastsinliverfibrosis AT paikyonghan originofmyofibroblastsinliverfibrosis AT iwaisakokeiko originofmyofibroblastsinliverfibrosis AT inokuchisayaka originofmyofibroblastsinliverfibrosis AT schnablbernd originofmyofibroblastsinliverfibrosis AT sekiekihiro originofmyofibroblastsinliverfibrosis AT deminicissamuele originofmyofibroblastsinliverfibrosis AT oesterreicherchristoph originofmyofibroblastsinliverfibrosis AT taurakojiro originofmyofibroblastsinliverfibrosis |